Researchers from UC San Francisco have discovered a way to reverse severe forms of epilepsy in mice with stem cells, providing a new sense of hope for patients who suffer from the seizure-inducing disorder.
LATEST EFGC NEWS
Children born to mothers who took the anti-seizure drug valproate were five times more likely to be born with autism than those whose mothers didn’t take the medication, a Danish study found.
EFGC’s Debbie Flader receives the Sara Stubblefield Advocacy Award from the national Epilepsy Foundation
Debbie Flader of Hanover Park, IL received the national Epilepsy Foundation’s Sara Stubblefield Advocacy Award for her years of tireless service as the Epilepsy Foundation of Greater Chicago’s Director of Clinical Outreach. The award was given at the Epilepsy Foundation’s 2013 Public Policy Institute in Washington, DC.
President Obama will unveil a $100 million initiative to research the human brain, in hopes of unlocking further understanding of brain disorders.
The Epilepsy Foundation is currently conducting a Needs Assessment Survey in order to collect information that will help determine “unmet needs” among its consumers. This is a confidential and simple questionnaire that can be completed online. Information gathered from this survey will help the Foundation create or improve its programs and services, validate its activities, and find further ways to better serve the community. Please take a few minutes to complete this questionnaire by April 30th. Your feedback is much appreciated!
An implanted neurological device that is intended to reduce the frequency of epileptic seizures gained the unanimous backing of an FDA advisory panel Friday.
This fall the Epilepsy Foundation of Greater Chicago will be participating in both the Bank of America Chicago Marathon and the Inaugural Naperville Marathon and Half Marathon charity programs! You can become a member of Team EFGC and help us raise much needed funds to support the programs and services we provide.